We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
226
Creative Planning
Kansas
$932K +$130K +1,023 +19%
SC
227
Sawyer & Company
Massachusetts
$919K +$789K +6,210 New
AIMCA
228
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$902K +$775K +6,100 New
MSV
229
MN Services Vermogensbeheer
Netherlands
$887K -$12.7K -100 -1%
BCIM
230
British Columbia Investment Management
British Columbia, Canada
$883K +$378K +2,974 +99%
Mitsubishi UFJ Asset Management
231
Mitsubishi UFJ Asset Management
Japan
$879K -$19.1K -150 -2%
Twin Tree Management
232
Twin Tree Management
Texas
$873K +$751K +5,904 New
PNC Financial Services Group
233
PNC Financial Services Group
Pennsylvania
$862K +$83.3K +655 +13%
NIM
234
Nicollet Investment Management
Minnesota
$858K +$737K +5,800 New
FAAS
235
First Allied Advisory Services
California
$842K +$96.4K +758 +15%
NMIMC
236
Northwestern Mutual Investment Management Company
Wisconsin
$837K -$3.05K -24 -0.4%
LS
237
Livforsakringsbolaget Skandia
Sweden
$834K -$25.4K -200 -3%
SF
238
Synovus Financial
Georgia
$829K -$15.1K -119 -2%
SIAP
239
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$799K +$159K +1,250 +30%
US Bancorp
240
US Bancorp
Minnesota
$788K +$152K +1,195 +29%
SAM
241
Securian Asset Management
Minnesota
$787K -$21.7K -171 -3%
JIC
242
Johnson Investment Counsel
Ohio
$784K -$29.9K -235 -4%
GIA
243
Gargoyle Investment Advisor
New Jersey
$720K -$422K -3,323 -41%
GHCM
244
Glen Harbor Capital Management
California
$705K +$234K +1,840 +63%
SAM
245
Selway Asset Management
$692K -$25.4K -200 -4%
BCM
246
Bayesian Capital Management
New York
$681K +$585K +4,600 New
NAM
247
Nissay Asset Management
Japan
$676K +$580K +4,566 New
OA
248
Oak Associates
Ohio
$672K +$168K +1,320 +41%
SRAM
249
Stone Ridge Asset Management
New York
$666K +$572K +4,500 New
KCM
250
Kendall Capital Management
Maryland
$649K +$557K +4,385 New
8 9
10
11 12

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.